These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 27793198

  • 1. Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.
    Geerdink JX, Simons SO, Pike R, Stauss HJ, Heijdra YF, Hurst JR.
    Respir Res; 2016 Oct 28; 17(1):140. PubMed ID: 27793198
    [Abstract] [Full Text] [Related]

  • 2. Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD.
    Capozzolo A, Carratù P, Dragonieri S, Falcone VA, Quaranta VN, Liotino V, D'Alba G, Castellana G, Resta O.
    Respir Care; 2017 May 28; 62(5):572-578. PubMed ID: 28270543
    [Abstract] [Full Text] [Related]

  • 3. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
    Reilev M, Lykkegaard J, Halling A, Vestbo J, Søndergaard J, Pottegård A.
    NPJ Prim Care Respir Med; 2017 Apr 17; 27(1):25. PubMed ID: 28416794
    [Abstract] [Full Text] [Related]

  • 4. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
    Tomioka R, Kawayama T, Suetomo M, Kinoshita T, Tokunaga Y, Imaoka H, Matsunaga K, Okamoto M, Hoshino T.
    Int J Chron Obstruct Pulmon Dis; 2016 Apr 17; 11():207-16. PubMed ID: 26893552
    [Abstract] [Full Text] [Related]

  • 5. Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression.
    Halper-Stromberg E, Yun JH, Parker MM, Singer RT, Gaggar A, Silverman EK, Leach S, Bowler RP, Castaldi PJ.
    Am J Respir Cell Mol Biol; 2018 Apr 17; 58(4):500-509. PubMed ID: 29206476
    [Abstract] [Full Text] [Related]

  • 6. The Role of Human Leukocyte Antigen-DR in Regulatory T Cells in Patients with Virus-Induced Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Zhang L, Nie X, Luo Z, Wei B, Teng G.
    Med Sci Monit; 2021 Mar 02; 27():e928051. PubMed ID: 33651771
    [Abstract] [Full Text] [Related]

  • 7. Antiviral immunity is impaired in COPD patients with frequent exacerbations.
    Singanayagam A, Loo SL, Calderazzo M, Finney LJ, Trujillo Torralbo MB, Bakhsoliani E, Girkin J, Veerati P, Pathinayake PS, Nichol KS, Reid A, Footitt J, Wark PAB, Grainge CL, Johnston SL, Bartlett NW, Mallia P.
    Am J Physiol Lung Cell Mol Physiol; 2019 Dec 01; 317(6):L893-L903. PubMed ID: 31513433
    [Abstract] [Full Text] [Related]

  • 8. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J, Díaz O, Repetto PB, Morales A, Saldías F, Lisboa C.
    Int J Chron Obstruct Pulmon Dis; 2015 Dec 01; 10():525-33. PubMed ID: 25792820
    [Abstract] [Full Text] [Related]

  • 9. Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood.
    Freeman CM, Martinez CH, Todt JC, Martinez FJ, Han MK, Thompson DL, McCloskey L, Curtis JL.
    Respir Res; 2015 Aug 05; 16(1):94. PubMed ID: 26243260
    [Abstract] [Full Text] [Related]

  • 10. Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease.
    Popescu I, Drummond MB, Gama L, Coon T, Merlo CA, Wise RA, Clements JE, Kirk GD, McDyer JF.
    Am J Respir Crit Care Med; 2014 Oct 01; 190(7):744-55. PubMed ID: 25137293
    [Abstract] [Full Text] [Related]

  • 11. Serum Amyloid A in Stable COPD Patients is Associated with the Frequent Exacerbator Phenotype.
    Zhao D, Abbasi A, Rossiter HB, Su X, Liu H, Pi Y, Sang L, Zhong W, Yang Q, Guo X, Zhou Y, Li T, Casaburi R, Zhang N.
    Int J Chron Obstruct Pulmon Dis; 2020 Oct 01; 15():2379-2388. PubMed ID: 33061355
    [Abstract] [Full Text] [Related]

  • 12. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM, Sheen SS, Park JH, Jin UR, Yoo JW, Seo JB, Yoo KH, Lee JH, Kim TH, Lim SY, Yoon HI, Lee JS, Lee SD.
    Int J Tuberc Lung Dis; 2014 Dec 01; 18(12):1407-14. PubMed ID: 25517804
    [Abstract] [Full Text] [Related]

  • 13. Impaired Blood Neutrophil Function in the Frequent Exacerbator of Chronic Obstructive Pulmonary Disease: A Proof-of-Concept Study.
    Jones AW, Robinson R, Mohamed P, Davison G, Izzat HJ, Lewis KE.
    Lung; 2016 Dec 01; 194(6):881-887. PubMed ID: 27530251
    [Abstract] [Full Text] [Related]

  • 14. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.
    McGarvey L, Lee AJ, Roberts J, Gruffydd-Jones K, McKnight E, Haughney J.
    Respir Med; 2015 Feb 01; 109(2):228-37. PubMed ID: 25613107
    [Abstract] [Full Text] [Related]

  • 15. Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations.
    Scioscia G, Blanco I, Arismendi E, Burgos F, Gistau C, Foschino Barbaro MP, Celli B, O'Donnell DE, Agustí A.
    Thorax; 2017 Feb 01; 72(2):117-121. PubMed ID: 27586869
    [Abstract] [Full Text] [Related]

  • 16. Analysis of Airway Thickening and Serum Cytokines in COPD Patients with Frequent Exacerbations: A Heart of the Matter.
    Lin Y, Sang L, Wang J, Chen Y, Lai J, Zhu X, Yang Y, Zhang Z, Liu Y, Wen S, Zhang N, Zhao D.
    Int J Chron Obstruct Pulmon Dis; 2023 Feb 01; 18():2353-2364. PubMed ID: 37928768
    [Abstract] [Full Text] [Related]

  • 17. Clinical Outcomes and Inflammatory Responses of the Frequent Exacerbator in Pulmonary Rehabilitation: A Prospective Cohort Study.
    Jenkins AR, Holden NS, Gibbons LP, Jones AW.
    COPD; 2020 Jun 01; 17(3):253-260. PubMed ID: 32362176
    [Abstract] [Full Text] [Related]

  • 18. Identification of proteomic signatures associated with COPD frequent exacerbators.
    Sun P, Ye R, Wang C, Bai S, Zhao L.
    Life Sci; 2019 Aug 01; 230():1-9. PubMed ID: 31121174
    [Abstract] [Full Text] [Related]

  • 19. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
    Fu JJ, McDonald VM, Baines KJ, Gibson PG.
    Chest; 2015 Sep 01; 148(3):618-629. PubMed ID: 25950204
    [Abstract] [Full Text] [Related]

  • 20. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
    Dilektasli AG, Demirdogen Cetinoglu E, Uzaslan E, Budak F, Coskun F, Ursavas A, Ercan I, Ege E.
    Int J Chron Obstruct Pulmon Dis; 2017 Sep 01; 12():199-208. PubMed ID: 28115842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.